Recently, HEK293T cell-derived sEVs with Lamp2b-anti-HER2 affibody fusion protein were shown to selectively bind HER2-expressing colon cancer cells, delivering 5-fluorouracil and miRNA inhibitors to tumor cells and suppressing tumor growth (Figure 3) (167). The gene discussed is ERBB2; the disease is malignant colon neoplasm.